<p>Exponetially growing FLC-resistant <i>C. albicans</i> 103 were treated with or without Gla (8, 16 µg/ml) for 12 h in YPD. Then they were diluted to 1×10<sup>7</sup> CFU/ml and 3 µl from 1∶5 serial dilutions were spotted onto YPD agar plates containing 15 µg/ml CFW or 100 µg/ml congored.</p
<p>Panels A and D show agar plates, and panel B shows an agar plate containing 64 µg/ml FLC. Panel C...
<p>The inhibitory rate of different concentrations of (CKPV)<sub>2</sub> against Candida albicans SA...
<p>CA10 cells were treated with t no agent, 1μg/mL FLC, 128μg/mL BUD, and a combination of FLC and B...
<p>Exponetially growing FLC-resistant <i>C. albicans</i> 103 were treated with or without different ...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with or without Gla (16, 32, 64 µg/ml), FLC (64...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with FLC (8 µg/ml), Gla (4 µg/ml) and FLC+Gla (...
<p>Exponetially growing FLC-resistant <i>C</i>. <i>albicans</i> 103 were treated with or without FLC...
<p>Wild-type C. albicans (CAF2) was grown overnight for ten generations in YPD medium, favoring yeas...
<p>FLC-resistant <i>C</i>. <i>albicans</i> 103 were treated with FLC (8 μg/ml), B-7b (4 μg/ml), BBR ...
<p>A. Several pairs of isogenic clinical isolates of <i>C. albicans</i> were tested with 0.02% SDS, ...
<p>(A) Minimum inhibitory concentration of H<sub>2</sub>O<sub>2</sub> was determined by broth diluti...
a<p>MIC and MFC in combination expressed as [FLC]/[Gla].</p>b<p>Syn, synergism. The number of strain...
<p>Antifungal susceptibility using disk diffusion assay for the lead compounds 3a and 3b against <i>...
<p>(A) Sequential isolates were tested with CW perturbing agents like Triton X-100 (upto 0.04%), 0.0...
<p>The cells were treated with two commonly used antifungal drugs, flucytosine and amphotericin B.</...
<p>Panels A and D show agar plates, and panel B shows an agar plate containing 64 µg/ml FLC. Panel C...
<p>The inhibitory rate of different concentrations of (CKPV)<sub>2</sub> against Candida albicans SA...
<p>CA10 cells were treated with t no agent, 1μg/mL FLC, 128μg/mL BUD, and a combination of FLC and B...
<p>Exponetially growing FLC-resistant <i>C. albicans</i> 103 were treated with or without different ...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with or without Gla (16, 32, 64 µg/ml), FLC (64...
<p>FLC-resistant <i>C. albicans</i> 103 were treated with FLC (8 µg/ml), Gla (4 µg/ml) and FLC+Gla (...
<p>Exponetially growing FLC-resistant <i>C</i>. <i>albicans</i> 103 were treated with or without FLC...
<p>Wild-type C. albicans (CAF2) was grown overnight for ten generations in YPD medium, favoring yeas...
<p>FLC-resistant <i>C</i>. <i>albicans</i> 103 were treated with FLC (8 μg/ml), B-7b (4 μg/ml), BBR ...
<p>A. Several pairs of isogenic clinical isolates of <i>C. albicans</i> were tested with 0.02% SDS, ...
<p>(A) Minimum inhibitory concentration of H<sub>2</sub>O<sub>2</sub> was determined by broth diluti...
a<p>MIC and MFC in combination expressed as [FLC]/[Gla].</p>b<p>Syn, synergism. The number of strain...
<p>Antifungal susceptibility using disk diffusion assay for the lead compounds 3a and 3b against <i>...
<p>(A) Sequential isolates were tested with CW perturbing agents like Triton X-100 (upto 0.04%), 0.0...
<p>The cells were treated with two commonly used antifungal drugs, flucytosine and amphotericin B.</...
<p>Panels A and D show agar plates, and panel B shows an agar plate containing 64 µg/ml FLC. Panel C...
<p>The inhibitory rate of different concentrations of (CKPV)<sub>2</sub> against Candida albicans SA...
<p>CA10 cells were treated with t no agent, 1μg/mL FLC, 128μg/mL BUD, and a combination of FLC and B...